DrugLog
Drug management and logging solution for oncology
Software · On PremiseCompany source
Company profile
About RaySearch Laboratories AB (PUBL)
RaySearch Laboratories is a leading developer of advanced software solutions for radiation therapy and oncology. The company's mission is to advance cancer treatment through pioneering software, working in close collaboration with leading cancer centers to bring scientific advancements faster to the clinical world. RaySearch's flagship product, RayStation, is a comprehensive treatment planning system that combines unique features including adaptive therapy capabilities, multi-criteria optimization, and support for multiple treatment modalities including photons, electrons, protons, helium and carbon ions. The system supports a wide range of treatment machines and provides automated planning capabilities powered by machine learning. RaySearch also offers RayCare, an oncology information system for digital workflows and treatment management, and RayIntelligence for oncology analytics. The company's solutions are designed to make oncology software faster, easier and more flexible, enabling safer and better care for cancer patients. Today, RaySearch's solutions support thousands of clinics worldwide in the fight against cancer, serving as a comprehensive control center for all treatment planning needs across multiple treatment modalities and machines.
Company description RaySearch Laboratories AB (PUBL) official website
Primary marketSurgical AI & Robotics
Commercial modelCommercial information available on request
Company presenceLinkedIn
Work at RaySearch Laboratories AB (PUBL)?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- Breast cancer
- Cancer (general)
- Oncology conditions requiring radiation therapy
Who it serves
- Cancer centers
- Hospitals
- Radiation therapy clinics
- Research institutions
Deployment & integration
Cloud Saas · On Premise deployment with recorded integration context.
Recorded integration context: CyberKnife, DICOM, RayCare PACS, TomoTherapy, Treatment machines (multiple vendors).
Geographic context
MarketsAsia (Japan, China) · Europe · Global · North America
Company sourceOfficial website
Company milestones
Platform expansion
RayStation v2026 released July 2026, RayIntelligence v2026 released June 2026
Partnerships
Recorded partners
- Akron General
- Ålesund Hospital
- NCCC
- Princess Margaret Hospital (Toronto, Canada)
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
Liver Ablation
Specialized planning solution for liver ablation procedures
Software · On PremiseCompany source
Micro RayStation
Planning and evaluation for pre-clinical research
Software · On PremiseCompany source
RayAutoBreast
Automated treatment planning for tangential breast IMRT
Software · On PremiseCompany source
RayCare
Oncology information system with digital workflows and treatment management
Platform · On PremiseCompany source
RayCommand
Treatment delivery and workflow management solution
Software · On PremiseCompany source
RayIntelligence
Advanced oncology analytics platform
Software · Cloud SaaSCompany source
RayMigrate
Data migration solution for oncology systems
Software · On PremiseCompany source
RayPlan
Treatment planning solution for radiation therapy
Software · On PremiseCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
No linked records are currently available.
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
RayStation 2023B, RayPlan 2023B, RayStation 2024A, RayPlan 2024A, RayStation 2024A SP3, RayPlan 2024A SP3K240398 · 510k · Apr 4, 2025
RayStation 12AK222312 · 510k · Mar 29, 2023
RayStation 11BK220141 · 510k · Apr 15, 2022
RayStation 11.0K211867 · 510k · Sep 8, 2021
RayStation 10.1K210645 · 510k · Jun 29, 2021
RayStationK200569 · 510k · Sep 24, 2020
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Time savings
20 minutes saved per patient with automated plan check routine at NCCC
Efficiency improvement
Automated breast planning provides faster adoption of IMRT with increased access to care
Quality improvement
Increased plan homogeneity and consistency through automation
Princess Margaret Hospital (PMH)
Large-scale clinical study evaluating automated treatment planning for IMRT for tangential breast treatments
Concluded that automated planning adds tremendous degrees of efficiency and standardization, as well as quality to treatment planning processes
Akron General
Implementation of scripting capabilities in RayStation for automation
Automated treatment planning processes and reduced manual tasks
Ålesund Hospital
Using RayStation scripting to automate manual tasks and optimize treatment planning workflow
Replaced large number of manual tasks with automation, achieving a flying start to treatment planning process with decently optimized plans from the start
NCCC (National Cancer Care Centre)
Automated plan check routine using RayStation scripting to increase safety and plan consistency
Saves 20 minutes per patient while increasing safety and plan homogeneity
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Updates from RaySearch Laboratories AB (PUBL)
Recent articles published on RaySearch Laboratories AB (PUBL)'s official website.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Surgical AI & Robotics
Companies developing surgical technologies enhanced by AI, including robotic surgical systems, AI-powered surgical assistance and navigation tools, autonomous surgical robotics, and surgical data and analytics platforms. Covers both the performance of surgery and the analysis of surgical outcomes and OR efficiency.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.